1.
Çokgezer S, Senkal M, Safaraliyeva A, Bozbey HU, Taştekin D. Hematologic Toxicity During First-Line Platinum-Based Chemotherapy in BRCA-Mutated Ovarian Cancer: Predictors and Survival Impact. Cerrahpaşa Medical Journal [Internet]. 2026 Jul. 28 [cited 2026 Aug. 9];50:1-8. Available from: https://cerrahpasamedj.org/index.php/pub/article/view/1067